Genes (Jan 2022)

The Role of <i>TRPM4</i> Gene Mutations in Causing Familial Progressive Cardiac Conduction Disease: A Further Contribution

  • Alberto Palladino,
  • Andrea Antonio Papa,
  • Roberta Petillo,
  • Marianna Scutifero,
  • Salvatore Morra,
  • Luigia Passamano,
  • Vincenzo Nigro,
  • Luisa Politano

DOI
https://doi.org/10.3390/genes13020258
Journal volume & issue
Vol. 13, no. 2
p. 258

Abstract

Read online

Progressive cardiac conduction disease (PCCD) is a relatively common condition in young and elderly populations, related to rare mutations in several genes, including SCN5A, SCN1B, LMNA and GJA5, TRPM4. Familial cases have also been reported. We describe a family with a large number of individuals necessitating pacemaker implantation, likely due to varying degrees of PCCD. The proband is a 47-year-old-patient, whose younger brother died at 25 years of unexplained sudden cardiac death. Three paternal uncles needed a pacemaker (PM) implantation between 40 and 65 years for unspecified causes. At the age of 42, he was implanted with a PM for two episodes of syncope and the presence of complete atrioventricular block (AVB). NGS analysis revealed the missense variation c. 2351G>A, p.Gly844Asp in the exon 17 of the TRPM4 gene. This gene encodes the TRPM4 channel, a calcium-activated nonselective cation channel of the transient receptor potential melastatin (TRPM) ion channel family. Variations in TRPM4 have been shown to cause an increase in cell surface current density, which results in a gain of gene function. Our report broadens and supports the causative role of TRPM4 gene mutations in PCCD. Genetic screening and identification of the causal mutation are critical for risk stratification and family counselling.

Keywords